Dr. Steven R. Goldstein is a globally recognized authority in obstetrics and gynecology whose pioneering work has transformed gynecologic ultrasound, menopause management, and midlife women’s health over more than four decades. A tenured professor of obstetrics and gynecology at the NYU Grossman School of Medicine, he exemplifies the integration of academic excellence, clinical innovation, and global leadership in women’s healthcare.
After graduating magna cum laude and Phi Beta Kappa from Colgate University in 1971, Dr. Goldstein earned his M.D. from NYU School of Medicine in 1975, followed by residency training at NYU/Bellevue Hospital Center. His early adoption of imaging technology and commitment to advancing care across the female lifespan rapidly distinguished him as a visionary in his field.
As director of gynecologic ultrasound at NYU Langone Medical Center for over 20 years, Dr. Goldstein has fundamentally reshaped clinical assessment of abnormal uterine bleeding, endometrial disease, and early pregnancy loss through the use of advanced transvaginal imaging. His scholarly work—featured in leading journals and foundational textbooks like Endovaginal Ultrasound and Ultrasound in Gynecology—has established global standards and influenced clinical guidelines across multiple specialties.
Dr. Goldstein has held presidencies at the American Institute of Ultrasound in Medicine (AIUM), the North American Menopause Society (NAMS), and the International Menopause Society (IMS), affirming his status as a preeminent voice in women’s health. A globally sought-after educator, he has delivered more than 200 invited lectures in over 20 countries, mentoring thousands of clinicians in best practices for menopause care, bone health, and diagnostic ultrasound.
His clinical expertise is anchored in board certification by the American Board of Obstetrics and Gynecology and advanced credentials including certified menopause practitioner (NAMS), clinical densitometrist (ISCD), and extensive specialization in hormonal therapies, SERMs, osteoporosis management, and cancer risk assessment. He has led or contributed to numerous clinical trials and data safety monitoring boards (DSMBs) for leading pharmaceutical and biotech companies, including Agile Therapeutics, Amag, Evofem, IBSA, and Mithra, among others.
Dr. Goldstein has been a board member of Sonosite Inc., a publicly traded point-of-care ultrasound company, and has consulted for a wide range of pharmaceutical and medical device innovators including Pfizer, Bayer, Merck, Teva, GE Ultrasound, Cooper Surgical, Gynesonics, PulseNmore, and Illumigyn. His work has influenced the development of cutting-edge technologies in AI-guided ultrasound, endometrial ablation, hysteroscopic devices, and remote imaging platforms.
In the business and policy arena, Dr. Goldstein has served as a consultant for global firms such as L.E.K. Consulting, Cambridge Consultants, and Cowen, advising on product development, marketing strategy, and healthcare investment. He has collaborated with multiple medical communication and education platforms, including Healthcasts, MedPanel, World Class CME, and others, extending his impact on clinical decision-making and continuing medical education.
A prolific inventor, Dr. Goldstein holds four U.S. patents related to uterine fluid instillation devices, global endometrial ablation systems, and vaginal delivery platforms for SERMs, underscoring his role in shaping the next generation of gynecologic interventions. He has also served as an expert witness on patent matters for companies including Bayer and Eli Lilly.
Among his many accolades, Dr. Goldstein has received the Joseph H. Holmes Clinical Pioneer Award from AIUM, the Ian Donald Gold Medal from ISUOG, and was inducted into Alpha Omega Alpha for faculty excellence. His commitment to education includes a 25-year leadership role in NYU’s Resident Journal Club and a lifelong dedication to mentoring students, residents, and fellows.
Dr. Goldstein’s legacy lies at the nexus of clinical compassion, academic rigor, and innovative foresight—empowering a global healthcare community to advance the lives and well-being of women everywhere.
Character: Dr. Goldstein’s lifelong dedication to advancing women’s health and mentoring future clinicians reflects his integrity, compassion, and commitment to excellence in patient care and education.
Knowledge: With decades of clinical and academic leadership, Dr. Goldstein is a globally recognized expert in gynecologic ultrasound, menopause, and midlife women’s health, having authored seminal research and medical texts in the field.
Strategic: As a past president of major international medical societies and lead investigator in numerous clinical trials, he has consistently shaped healthcare policy, clinical guidelines, and technological advancement in women’s medicine.
Communication: A prolific speaker and educator, Dr. Goldstein has delivered hundreds of presentations worldwide, translating complex clinical insights into practical guidance for physicians and patients alike.
